Definium Therapeutics
Develops psychedelic-based pharmaceutical treatments for psychiatric disorders.
Company facts
- Founded
- 2019
- Employees
- 106
- Headquarters
- United States
- Type
- Public
- Listed
- Nasdaq: DFTX
- Subsidiaries
- MindMed Discover, MindMed Pty Ltd.
Open positions
Director, Field Operations
Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible…
Manager, Data & Analytics
Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible…
Director, Medical Communications
Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible…